ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:09 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 171
Drug details and screening numbers
Drug Name: AKT inhibitor VIII
Drug ID: 171
Synonyms:
Brand name:
Target: AKT1, AKT2, AKT3
Number of cell lines screened: 881
Screening concentration range(s): 0.01 to 2.56 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a149 |
ATM_mut |
171 |
1 |
1 |
AKT inhibitor VIII |
AKT1, AKT2, AKT3 |
23 |
855 |
0.94 |
2.26 |
2.99 |
0.728 |
0.72 . |
0.72 . |
0.87 . |
3.8e-05 |
9.28e-07 |
7.14e-03 |
4.2 |
All-tests volcano plot